Given that the preexisting lymphocyte infiltration is crucial for immunotherapy efficacy [158], this otherwise drug-efficacy-lowering PD-L1 expression ultimately results in a substantially more effective tumor cell killing after anti-PD-1 treatment. This evidence concerns the gene CD274 and neoplasm.